Antiplatelet activity of carvedilol in comparison to propranolol

By Petríková M.   Jancinová V.   Nosál R.   Májeková M.   Danihelová E.  

Platelets, Vol. 13, Iss. 8, 2002-12 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite

Systemic and Portal Hemodynamic Response to Propranolol in Patients with Portal Hypertension Due to Hepatitis C Virus

By  

Medical Principles and Practice, Vol. 7, Iss. 3, 1998-09 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience

By Heebøll Sara   Villadsen Gerda Elisabeth   Aagaard Niels Kristian   Grønbæk Henning   Vilstrup Hendrik   Keiding Susanne  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 8, 2013-08 ,pp. : 969-973

Informa Healthcare

Access to resources Recommend Favorite

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial

By Poole-Wilson P.A.   Swedberg K.   Cleland J.G.F.   for the COMET Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 45-45

Elsevier

Access to resources Recommend Favorite

Antioxidative Actions of Carvedilol in the Treatment of Hypertension

By  

Current Cardiology Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 147-151

Bentham Science Publishers

Access to resources Recommend Favorite